Mammograms and Mortality

How Has the Evidence Evolved

Datos Bibliográficos

ID4029318
AutoresAmanda E Kowalski (Amanda E. Kowalski is Gail Wilensky Professor of Applied Economics and Public Policy, University of Michigan, Ann Arbor, Michigan. Her email address is a.), Amanda Kowalski (0000-0002-0221-8826, University of Michigan, autor de correspondencia)
Año2021
Volumen35
Número2
Páginas119-140
Fecha de publicación2021-05-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaThe Journal of Economic Perspectives (JOURNAL)
Identificadores de la revistaISSN: 0895-3309 • E-ISSN: 1944-7965
EditorialAmerican Economic Association (PUBLISHER • US)
DOI10.1257/jep.35.2.119
PMID34421215
OpenAlexW3146503876
IdiomaEN
Citas recibidas4
Referencias citadas13

Decades of evidence reveal a complicated relationship between mammograms and mortality. Mammograms may detect deadly cancers early, but they may also lead to the diagnosis and potentially fatal treatment of cancers that would never progress to cause symptoms. I provide a brief history of the evidence on mammograms and mortality, focusing on evidence from clinical trials, and I discuss how this evidence informs mammography guidelines. I then explore the evolution of all-cause mortality relative to breast cancer mortality within an influential clinical trial. I conclude with some responses to the evolving evidence

Breast cancer · Cancer · Clinical trial · Intensive care medicine · Mammography · Pathology · Cancer Risks and Factors · Colorectal Cancer Screening and Detection · Global Cancer Incidence and Screening · Medicine · Internal Medicine